SEARCH

SEARCH BY CITATION

REFERENCES

  • Albert MS. 2011. Changes in cognition. Neurobiol Aging 32 (Suppl 1):S58S63.
  • Alkam T, Nitta A, Mizoguchi H, Itoh A, Nabeshima T. 2007. A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Abeta(25–35). Behav Brain Res 180:139145.
  • Armstrong RA. 2011. The pathogenesis of Alzheimer's disease: A reevaluation of the “amyloid cascade hypothesis”. Int J Alzheimers Dis 2011:630865.
  • Barria A, Muller D, Derkach V, Griffith LC, Soderling TR. 1997. Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation. Science 276:20422045.
  • Bateman RJ, Xiong C, Benzinger TL, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, et al. 2012. Clinical and biomarker changes in dominantly inherited Alzheimer's disease. N Engl J Med 367:795804.
  • Bliss TV, Collingridge GL. 1993. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361:3139.
  • Burwell RD, Saddoris MP, Bucci DJ, Wiig KA. 2004. Corticohippocampal contributions to spatial and contextual learning. J Neurosci 24:38263836.
  • Caricasole A, Bruno V, Cappuccio I, Melchiorri D, Copani A, Nicoletti F. 2002. A novel rat gene encoding a Humanin-like peptide endowed with broad neuroprotective activity. FASEB J 16:13311333.
  • Chen QS, Kagan BL, Hirakura Y, Xie CW. 2000. Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides. J Neurosci Res 60:6572.
  • Chiba T, Yamada M, Sasabe J, Terashita K, Shimoda M, Matsuoka M, Aiso S. 2009. Amyloid-beta causes memory impairment by disturbing the JAK2/STAT3 axis in hippocampal neurons. Mol Psychiatry 14:206222.
  • Cooke SF, Bliss TV. 2006. Plasticity in the human central nervous system. Brain 129 (Part 7):16591673.
  • Cui AL, Zhao L, Li LM, Qiao JT, Zhang C. 2006. Recent progress in neuroprotection of humanin against Alzheimer's disease-relevant neurotoxicity. Sheng Li Ke Xue Jin Zhan 37:302306.
  • D'Amelio M, Cavallucci V, Middei S, Marchetti C, Pacioni S, Ferri A, Diamantini A, De Zio D, Carrara P, Battistini L, et al. 2011. Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease. Nat Neurosci 14:6976.
  • Dadic-Hero E, Grahovac T, Kovac M. 2011. Changes in life-quality, a possible symptom of dementia development. Coll Antropol 35 (Suppl 2):245246.
  • Ferreira ST, Vieira MN, De Felice FG. 2007. Soluble protein oligomers as emerging toxins in Alzheimer's and other amyloid diseases. IUBMB Life 59:332345.
  • Fjell AM, Walhovd KB. 2012. Neuroimaging results impose new views on Alzheimer's disease—The role of amyloid revised. Mol Neurobiol 45:153172.
  • Freir DB, Holscher C, Herron CE. 2001. Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J Neurophysiol 85:708713.
  • Freir DB, Costello DA, Herron CE. 2003. A beta 25–35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil. J Neurophysiol 89:30613069.
  • Guo F, Jing W, Ma CG, Wu MN, Zhang JF, Li XY, Qi JS. 2010. [Gly(14)]-humanin rescues long-term potentiation from amyloid beta protein-induced impairment in the rat hippocampal CA1 region in vivo. Synapse 64:8391.
  • Han WN, Holscher C, Yuan L, Yang W, Wang XH, Wu MN, Qi JS. 2012. Liraglutide protects against amyloid-beta protein-induced impairment of spatial learning and memory in rats. Neurobiol Aging 34:576588.
  • Hashimoto Y, Niikura T, Ito Y, Sudo H, Hata M, Arakawa E, Abe Y, Kita Y, Nishimoto I. 2001a. Detailed characterization of neuroprotection by a rescue factor humanin against various Alzheimer's disease-relevant insults. J Neurosci 21:92359245.
  • Hashimoto Y, Niikura T, Tajima H, Yasukawa T, Sudo H, Ito Y, Kita Y, Kawasumi M, Kouyama K, Doyu M, et al. 2001b. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta. Proc Natl Acad Sci USA 98:63366341.
  • Hashimoto Y, Suzuki H, Aiso S, Niikura T, Nishimoto I, Matsuoka M. 2005. Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotection. Life Sci 77:30923104.
  • He Y, Zheng MM, Ma Y, Han XJ, Ma XQ, Qu CQ, Du YF. 2012. Soluble oligomers and fibrillar species of amyloid beta-peptide differentially affect cognitive functions and hippocampal inflammatory response. Biochem Biophys Res Commun 429:125130.
  • Izuo N, Kume T, Sato M, Murakami K, Irie K, Izumi Y, Akaike A. 2012. Toxicity in rat primary neurons through the cellular oxidative stress induced by the turn formation at positions 22 and 23 of Abeta42. ACS Chem Neurosci 3:674681.
  • Jung SS, Van Nostrand WE. 2003. Humanin rescues human cerebrovascular smooth muscle cells from Abeta-induced toxicity. J Neurochem 84:266272.
  • Kanski J, Aksenova M, Butterfield DA. 2002a. The hydrophobic environment of Met35 of Alzheimer's Abeta(1–42) is important for the neurotoxic and oxidative properties of the peptide. Neurotox Res 4:219223.
  • Kanski J, Varadarajan S, Aksenova M, Butterfield DA. 2002b. Role of glycine-33 and methionine-35 in Alzheimer's amyloid beta-peptide 1–42-associated oxidative stress and neurotoxicity. Biochim Biophys Acta 1586:190198.
  • Kariya S, Takahashi N, Ooba N, Kawahara M, Nakayama H, Ueno S. 2002. Humanin inhibits cell death of serum-deprived PC12h cells. Neuroreport 13:903907.
  • Kariya S, Hirano M, Nagai Y, Furiya Y, Fujikake N, Toda T, Ueno S. 2005. Humanin attenuates apoptosis induced by DRPLA proteins with expanded polyglutamine stretches. J Mol Neurosci 25:165169.
  • Kunesova G, Hlavacek J, Patocka J, Evangelou A, Zikos C, Benaki D, Paravatou-Petsotas M, Pelecanou M, Livaniou E, Slaninova J. 2008. The multiple T-maze in vivo testing of the neuroprotective effect of humanin analogues. Peptides 29:19821987.
  • Le Y, Gong W, Tiffany HL, Tumanov A, Nedospasov S, Shen W, Dunlop NM, Gao JL, Murphy PM, Oppenheim JJ, et al. 2001. Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J Neurosci 21:RC123.
  • Li LM, Liu QH, Qiao JT, Zhang C. 2009. Abeta(31–35)-induced neuronal apoptosis is mediated by JNK-dependent extrinsic apoptosis pathway. Neurosci Bull 25:361366.
  • Li LM, Zhang Y, Qiao JT, Zhang C. 2010. Humanin protects neurons against apoptosis induced by Abeta31–35 through suppression of intrinsic pathway. Sheng Li Xue Bao 62:93100.
  • Li SF, Wu MN, Wang XH, Yuan L, Yang D, Qi JS. 2011. Requirement of alpha7 nicotinic acetylcholine receptors for amyloid beta protein-induced depression of hippocampal long-term potentiation in CA1 region of rats in vivo. Synapse 65:11361143.
  • Luo S, Lan T, Liao W, Zhao M, Yang H. 2012. Genistein inhibits abeta(25–35)-induced neurotoxicity in PC12 cells via PKC signaling pathway. Neurochem Res 37:27872794.
  • Manzoni C, Colombo L, Bigini P, Diana V, Cagnotto A, Messa M, Lupi M, Bonetto V, Pignataro M, Airoldi C, Sironi E, William A, Salmona M. 2011. The molecular assembly of amyloid abeta controls its neurotoxicity and binding to cellular proteins. PLoS One 6:e24909.
  • Matsuoka M. 2009. Humanin: A defender against Alzheimer's disease? Recent Pat CNS Drug Discov 4:3742.
  • Mattson MP. 2004. Pathways towards and away from Alzheimer's disease. Nature 430:631639.
  • Maurice T, Lockhart BP, Su TP, Privat A. 1996. Reversion of beta 25–35-amyloid peptide-induced amnesia by NMDA receptor-associated glycine site agonists. Brain Res 731:249253.
  • Misiti F, Sampaolese B, Pezzotti M, Marini S, Coletta M, Ceccarelli L, Giardina B, Clementi ME. 2005. Abeta(31–35) peptide induce apoptosis in PC 12 cells: Contrast with Abeta(25–35) peptide and examination of underlying mechanisms. Neurochem Int 46:575583.
  • Morris R. 1984. Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11:4760.
  • Onoue S, Endo K, Ohshima K, Yajima T, Kashimoto K. 2002. The neuropeptide PACAP attenuates beta-amyloid (1–42)-induced toxicity in PC12 cells. Peptides 23:14711478.
  • Pan YF, Chen XR, Wu MN, Ma CG, Qi JS. 2010. Arginine vasopressin prevents against Abeta(25–35)-induced impairment of spatial learning and memory in rats. Horm Behav 57:448454.
  • Prediger RD, Franco JL, Pandolfo P, Medeiros R, Duarte FS, Di Giunta G, Figueiredo CP, Farina M, Calixto JB, Takahashi RN, et al. 2007. Differential susceptibility following beta-amyloid peptide-(1–40) administration in C57BL/6 and Swiss albino mice: Evidence for a dissociation between cognitive deficits and the glutathione system response. Behav Brain Res 177:205213.
  • Qi JS, Qiao JT. 2001. Amyloid beta-protein fragment 31–35 forms ion channels in membrane patches excised from rat hippocampal neurons. Neuroscience 105:845852.
  • Qi JS, Ye L, Qiao JT. 2004. Amyloid beta-protein fragment 31–35 suppresses delayed rectifying potassium channels in membrane patches excised from hippocampal neurons in rats. Synapse 51:165172.
  • Quan M, Zheng C, Zhang N, Han D, Tian Y, Zhang T, Yang Z. 2011. Impairments of behavior, information flow between thalamus and cortex, and prefrontal cortical synaptic plasticity in an animal model of depression. Brain Res Bull 85:109116.
  • Rabinovici GD, Jagust WJ. 2009. Amyloid imaging in aging and dementia: Testing the amyloid hypothesis in vivo. Behav Neurol 21:117128.
  • Roozendaal B, Hahn EL, Nathan SV, de Quervain DJ, McGaugh JL. 2004. Glucocorticoid effects on memory retrieval require concurrent noradrenergic activity in the hippocampus and basolateral amygdala. J Neurosci 24:81618169.
  • Selkoe DJ. 2008. Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav Brain Res 192:106113.
  • Selznick LA, Zheng TS, Flavell RA, Rakic P, Roth KA. 2000. Amyloid beta-induced neuronal death is bax-dependent but caspase-independent. J Neuropathol Exp Neurol 59:271279.
  • Sponne I, Fifre A, Koziel V, Kriem B, Oster T, Pillot T. 2004. Humanin rescues cortical neurons from prion-peptide-induced apoptosis. Mol Cell Neurosci 25:95102.
  • Tajima H, Kawasumi M, Chiba T, Yamada M, Yamashita K, Nawa M, Kita Y, Kouyama K, Aiso S, Matsuoka M, et al. 2005. A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice. J Neurosci Res 79:714723.
  • Terashita K, Hashimoto Y, Niikura T, Tajima H, Yamagishi Y, Ishizaka M, Kawasumi M, Chiba T, Kanekura K, Yamada M, et al. 2003. Two serine residues distinctly regulate the rescue function of Humanin, an inhibiting factor of Alzheimer's disease-related neurotoxicity: Functional potentiation by isomerization and dimerization. J Neurochem 85:15211538.
  • Terry AV Jr. 2009. Spatial navigation (water maze) tasks. In: Buccafusco JJ, editor. Source Methods of Behavior Analysis in Neuroscience. 2nd edition. Boca Raton (FL): CRC Press; 2009. Chapter 13.
  • Varadarajan S, Yatin S, Kanski J, Jahanshahi F, Butterfield DA. 1999. Methionine residue 35 is important in amyloid beta-peptide-associated free radical oxidative stress. Brain Res Bull 50:133141.
  • Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ. 2002. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416:535539.
  • Wang HW, Pasternak JF, Kuo H, Ristic H, Lambert MP, Chromy B, Viola KL, Klein WL, Stine WB, Krafft GA, et al. 2002. Soluble oligomers of beta amyloid (1–42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res 924:133140.
  • Wang XH, Li L, Holscher C, Pan YF, Chen XR, Qi JS. 2010. Val8-glucagon-like peptide-1 protects against Abeta1–40-induced impairment of hippocampal late-phase long-term potentiation and spatial learning in rats. Neuroscience 170:12391248.
  • Yamada M, Chiba T, Sasabe J, Terashita K, Aiso S, Matsuoka M. 2008. Nasal Colivelin treatment ameliorates memory impairment related to Alzheimer's disease. Neuropsychopharmacology 33:20202032.
  • Yamagishi Y, Hashimoto Y, Niikura T, Nishimoto I. 2003. Identification of essential amino acids in Humanin, a neuroprotective factor against Alzheimer's disease-relevant insults. Peptides 24:585595.
  • Yan XZ, Qiao JT, Dou Y, Qiao ZD. 1999. Beta-amyloid peptide fragment 31–35 induces apoptosis in cultured cortical neurons. Neuroscience 92:177184.
  • Yang Z, Zhang Q, Ge J, Tan Z. 2008. Protective effects of tetramethylpyrazine on rat retinal cell cultures. Neurochem Int 52:11761187.
  • Yenkoyan K, Safaryan K, Navasardyan G, Mkrtchyan L, Aghajanov M. 2009. Effects of beta-amyloid on behavioral and amino acids spectrum in rats' brain and their modulation by embryonic proteins. Neurochem Int 54:292298.
  • Ying G, Iribarren P, Zhou Y, Gong W, Zhang N, Yu ZX, Le Y, Cui Y, Wang JM. 2004. Humanin, a newly identified neuroprotective factor, uses the G protein-coupled formylpeptide receptor-like-1 as a functional receptor. J Immunol 172:70787085.
  • Zhang W, Miao J, Hao J, Li Z, Xu J, Liu R, Cao F, Wang R, Chen J. 2009. Protective effect of S14G-humanin against beta-amyloid induced LTP inhibition in mouse hippocampal slices. Peptides 30:11971202.
  • Zhang Y, Zhen Y, Dong Y, Xu Z, Yue Y, Golde TE, Tanzi RE, Moir RD, Xie Z. 2011. Anesthetic propofol attenuates the isoflurane-induced caspase-3 activation and Abeta oligomerization. PLoS One 6:e27019.
  • Zou P, Ding Y, Sha Y, Hu B, Nie S. 2003. Humanin peptides block calcium influx of rat hippocampal neurons by altering fibrogenesis of Abeta(1–40). Peptides 24:679685.